Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Possible neurologic effects of aspartame, a widely used food additive.

Maher TJ, Wurtman RJ.

Environ Health Perspect. 1987 Nov;75:53-7. Review.

2.

Aspartame: review of recent experimental and observational data.

Janssen PJ, van der Heijden CA.

Toxicology. 1988 Jun;50(1):1-26. Review.

PMID:
3291200
3.

Aspartame: clinical update.

Potenza DP, el-Mallakh RS.

Conn Med. 1989 Jul;53(7):395-400. Review.

PMID:
2667892
4.

Pharmacological effects of phenylalanine on seizure susceptibility: an overview.

Sze PY.

Neurochem Res. 1989 Feb;14(2):103-11. Review.

PMID:
2657469
5.

Aspartame intolerance.

Garriga MM, Metcalfe DD.

Ann Allergy. 1988 Dec;61(6 Pt 2):63-9. Review.

PMID:
3061324
6.

Aspartame: review of safety.

Butchko HH, Stargel WW, Comer CP, Mayhew DA, Benninger C, Blackburn GL, de Sonneville LM, Geha RS, Hertelendy Z, Koestner A, Leon AS, Liepa GU, McMartin KE, Mendenhall CL, Munro IC, Novotny EJ, Renwick AG, Schiffman SS, Schomer DL, Shaywitz BA, Spiers PA, Tephly TR, Thomas JA, Trefz FK.

Regul Toxicol Pharmacol. 2002 Apr;35(2 Pt 2):S1-93. Review.

PMID:
12180494
7.

Acceptable daily intake vs actual intake: the aspartame example.

Butchko HH, Kotsonis FN.

J Am Coll Nutr. 1991 Jun;10(3):258-66. Review.

PMID:
1894884
8.

The aspartame story: a model for the clinical testing of a food additive.

Stegink LD.

Am J Clin Nutr. 1987 Jul;46(1 Suppl):204-15. Review.

9.

Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies.

Magnuson BA, Burdock GA, Doull J, Kroes RM, Marsh GM, Pariza MW, Spencer PS, Waddell WJ, Walker R, Williams GM.

Crit Rev Toxicol. 2007;37(8):629-727. Review.

PMID:
17828671
10.

Postmarketing surveillance of food additives.

Butchko HH, Tschanz C, Kotsonis FN.

Regul Toxicol Pharmacol. 1994 Aug;20(1 Pt 1):105-18. Review.

PMID:
7838988
11.

Neurotoxicology of food additives.

Maher TJ.

Neurotoxicology. 1986 Summer;7(2):183-96. Review. No abstract available.

PMID:
3537851
12.

Direct and indirect cellular effects of aspartame on the brain.

Humphries P, Pretorius E, Naudé H.

Eur J Clin Nutr. 2008 Apr;62(4):451-62. Epub 2007 Aug 8. Review.

PMID:
17684524
13.

Can aspartame meet our expectations?

Horwitz DL, Bauer-Nehrling JK.

J Am Diet Assoc. 1983 Aug;83(2):142-6. Review.

PMID:
6348131
14.

Clinical safety of aspartame.

Yost DA.

Am Fam Physician. 1989 Feb;39(2):201-6. Review.

PMID:
2644789
15.

Effects of aspartame and phenylalanine on meal-time food intake of humans.

Anderson GH, Leiter LA.

Appetite. 1988;11 Suppl 1:48-53. Review.

PMID:
3056266
16.

Effects of aspartame metabolites on astrocytes and neurons.

Rycerz K, Jaworska-Adamu JE.

Folia Neuropathol. 2013;51(1):10-7. Review.

PMID:
23553132
17.

Use of aspartame in pregnancy.

Sturtevant FM.

Int J Fertil. 1985;30(1):85-7. Review.

PMID:
2862125
18.

Multiple chemical sensitivity: controlled scientific studies as proof of causation.

Tollefson L.

Regul Toxicol Pharmacol. 1993 Aug;18(1):32-43. Review.

PMID:
8234917
19.

Treatment of osteoarthritis with aspartame.

Edmundson AB, Manion CV.

Clin Pharmacol Ther. 1998 May;63(5):580-93. Review.

PMID:
9630831
20.

Mutagenic activity of peptides and the artificial sweetener aspartame after nitrosation.

Shephard SE, Wakabayashi K, Nagao M.

Food Chem Toxicol. 1993 May;31(5):323-9. Review.

PMID:
8505016
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk